U2AF65 Antibodies

Santa Cruz Biotechnology features a diverse variety of U2AF65 monoclonal antibodies for research focused on understanding U2AF65's role in pre-mRNA splicing and gene regulation. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). U2AF65, a critical splicing factor, is involved in the recognition of the 3' splice site of pre-mRNA, playing a vital role in the maturation of mRNA and the regulation of gene expression. Its function is essential for proper cellular processes, and dysregulation of U2AF65 has been implicated in various diseases, including cancer. Understanding the dynamics of U2AF65 can provide insights into the mechanisms of splicing-related disorders and potential therapeutic targets. Researchers can explore U2AF65's interaction with other splicing factors and its role in alternative splicing events. Advanced visualization techniques using fluorescent conjugates such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) enable detailed analysis of U2AF65 localization and function. Investigation of U2AF65's involvement in RNA processing pathways continues to reveal new aspects of gene regulation mechanisms. Santa Cruz Biotechnology monoclonal antibodies for U2AF65 support researchers worldwide in advancing scientific understanding of RNA splicing mechanisms and their impact on human health.